4.2 The Leishmaniasis Model

Methods in Microbiology

Volumn 25, Issue C, 1998, Pages 419-458

  Kropf, P ^a   Müller, I ^a   Brunson, K ^b   Etges, R ^c  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b SHSU   (United States)

^c UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956702061     PISSN: 05809517     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0580-9517(08)70688-3     Document Type: Article

References (117)

1. Abbas A.K., Murphy K.M., and Sher A. Functional diversity of helper T lymphocytes. Nature 383 (1996) 787-793
2. Afonso L.C.C., Scharton T.M., Vieira L.Q., Wysocka M., Trinchieri G., and Scott P. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263 (1994) 235-237
3. Anderson P., and Heron I. Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect. Immun. 61 (1993) 844-851
4. Behin R., Mauel J., and Sordat B. Leishmania tropica: pathogenicity and in vitro macrophage function in strains of inbred mice. Exp. Parasitol. 48 (1979) 81-91
5. Beverley S.M., and Turco S.J. Identification of genes mediating lipophosphoglycan biosynthesis by functional complementation of Leishmania donovani mutants. Ann. Trop. Med. Parasit. 89 (1995) 11-17 Supp. 1
6. Blackwell J.M. Genetic suscepibility to leishmanial infections: studies in mice and man. Parasitology 112 (1996) S67-S74
7. Blackwell J.M., Barton C.H., White J.K., Roach T.I.A., Shaw M.A., White-head S.H., Mock B.A., Searle S., Williams H., and Baker A.M. Genetic regulation of leishmanial and mycobacterial infections: the Lsh/Ity/Bcg gene story continues. Immunol. Lett. 43 (1994) 99-107
8. Bogdan C., Moll H., Solbach W., and Rollinghoff M. Tumor necrosis factor-α in combination with interferon-γ, but not with interleukin-4 activates murine macrophages for elimination of Leishmania major amastigotes. Eur. J. Immunol. 20 (1990) 1131-1135
9. Bogdan C., Gessner A., and Röllinghoff M. Cytokines in leishmaniasis: a complex network of stimulatory and inhibitory interactions. Immunobiology 189 (1993) 356-396
10. Bouvier J., Schneider P., Etges R., and Bordier C. Peptide substrate specificity of the membrane-bound metalloprotease of Leishmania. Biochemistry 29 (1990) 10113-10119
11. Bouvier J., Schneider P., and Etges R. Leishmanolysin: surface metalloproteinase of Leishmania. Methods Enzymol. 248 (1995) 614-633
12. Bretscher P.A., Wei G., Menon J.N., and Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes 'susceptible' mice resistant to Leishmania major. Science 257 (1992) 539-542
13. Brown D.R., Green J.M., Moskowitz N., Davis M., Thompson C.B., and Reiner S.L. Limited role of CD28-mediated signals in T helper subset differentiation. J. Exp. Med. 184 (1996) 803-810
14. Celada F. The cellular basis of immunological memory. Prog. Allergy 15 (1971) 223-267
15. Cerottini J.C., and MacDonald H.R. The cellular basis of T-cell memory. Annu. Rev. Immunol. 7 (1989) 77-89
16. Chatelain R., Varkila K., and Coffman R.L. IL-4 induces a Th2 response in Leishmania major-infected mice. /. Immunol. 148 (1992) 1182-1187
17. Coffman R.L., Lebman D.A., and Rothman P. Mechanism and regulation of immunoglobulin isotype switching. Adv. Immunol. 54 (1993) 229-270
18. Connell N.D., Medina-Acosta E., McMaster W.R., Bloom B.R., and Russell D.G. Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guerin expressing the Leishmania surface proteinase gp63. Proc. Natl Acad. Sci. U S A 90 (1993) 11473-11477
19. Da Silva R., and Sacks D.L. Metacyclogenesis is a major determinant of Leishmania promastigotes virulence and attenuation. Infect. Immun. 55 (1987) 2802-2806
20. Da Silva R.P., Hall B.F., Joiner K.A., and Sacks D.L. CR1, the C3b receptor mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. J. Immunol. 143 (1989) 617-622
21. Dialynas D.P., Quan Z.S., Wall K.A., Pierres A., Quintans J., Loken M.R., Pierres M., and Fitch F.W. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu3/T4 molecule. J. Immunol. 131 (1983) 2445-2451
22. Ding A.H., Nathan C.F., and Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for indepen- dent production. J. Immunol. 141 (1988) 2407-2412
23. Doherty T.M., and Coffman R.L. Leishmania major, effect of infectious dose on T cell subset development in BALB/c mice. Exp. Parasitol. 84 (1996) 124-135
24. - cells that make Th2 cytokines and help B cells. Science 260 (1993) 1802-1805
25. + T cells in resistance to cutaneous leishmaniasis in immunized mice. J. Immunol. 142 (1989) 2052-2056
26. Ferrick D.A., Schrenzel M.D., Mulvania T., Hsieh B., Ferlin W.G., and Lepper W. Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γ/δ T cells in vivo. Nature 373 (1995) 255-257
27. Freudenberg M.A., Keppler D., and Galanos C. Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect. Immun. 59 (1986) 891-895
28. Gajewski T.F., and Fitch F.W. Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J. Immunol. 140 (1988) 4245-4252
29. Gray D. Immunological memory. Annu. Rev. Immunol. 11 (1993) 49-77
30. Handman E., Ceredig R., and Mitchell G.F. Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages. Aust. ]. Exp. Biol. Med. 57 (1979) 9-29
31. Handman E., Schnur L.F., Spithill T.W., and Mitchell G.F. Passive transfer of Leishmania lipopolysaccharide confers parasite survival in macrophages. J. Immunol. 137 (1986) 3608-3613
32. Heinzel F.P., Sadick M.D., Holaday B.J., Coffman R.L., and Locksley R.M. Reciprocal expression of interferon-γ or interleukin-4 during the resolution or progression of murine leishmaniasis. J. Exp. Med. 169 (1989) 59-72
33. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl Acad. Sci. U S A 88 (1991) 7011-7015
34. Heinzel F.P., Rerko R.M., Hatam F., and Locksley R.M. IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts. J. Immunol. 150 (1993) 3924-3931
35. Heinzel F.P., Schoenhaut D.S., Rerko R.M., Rosser L.E., and Gately M.K. Recombinant interleukin-12 cures mice infected with Leishmania major. J. Exp. Med. 177 (1993) 1505-1509
36. Hill J.O., North R.J., and Collins F.M. Advantages of measuring changes in the number of viable parasites in murine models of experimental cutaneous leishmaniasis. Infect. Immun. 39 (1983) 1087-1094
37. Howard J.C., Hale G., and Liew F.Y. Immunological regulation of experimental cutaneous leishmaniasis. IV. Prophylactic effect of sublethal irradiation as a result of abrogation of suppressor T cell generation in mice genetically susceptible to tropica. J. Exp. Med. 153 (1981) 557-568
38. Ilg T., Stierhof Y.D., Etges R., Adrian M., Harbecke D., and Overath P. Secreted acid phosphatase of Leishmania mexicana: a filamentous phosphoglyco-protein polymer. Proc. Natl Acad. Sci. U S A 88 (1991) 8774-8778
39. Ilg T., Stierhof Y.D., Wiese M., McConville J., and Overath P. Characterization of phosphoglycan-containing secretory products of Leishmania. Parasitology 108 (1994) S63-S71
40. James S.L., and Hibbs Jr. J.B. The role of nitric oxides as effector molecules of parasite killing. Parasitol. Today 6 9 (1990) 303-305
41. Kelso A. Thl and Th2 subsets: paradigms lost?. Immunol. Today 16 (1995) 371-379
42. Kiderlen A.F., and Kaye P.M. A modified colorimetric assay of macrophage activation for intracellular cytotoxicity against Leishmania parasites. J. Immunol. Methods 127 (1990) 11-18
43. Kopf M., Brombacher F., Küohler G., Kienzle G., Widmann K.-H., Lefrang K., Humborg C., Ledermann B., and Solbach W. IL-4-deficient BALB/c mice resist infection with Leishmania major. J. Exp. Med. 184 (1996) 1127-1136
44. Kündig T.M., Bachmann M.F., Oehen S., Hoffmann U.W., Simard J.J.L., Kalberer C.P., Pircher H., Ohashi P.S., Hengartner H., and Zinkemagel R.M. On the role of antigen in maintaining cytotoxic T-cell memory. Proc. Natl Acad. Sci. U S A 93 (1996) 9716-9723
45. Leal L.M.C.C., Moss D.W., Kuhn R., Müller W., and Liew F.Y. Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection. Eur. J. Immunol. 23 (1993) 566-569
46. Leo O., Foo M., Sachs D.H., Samelson L.E., and Bluestone J.A. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl Acad. Sci. U S A 84 (1987) 1374-1378
47. + T cells in leishmaniasis. Immunol. Today 10 (1989) 40-45
48. Liew F.Y., and Cox F.E.G. Nonspecific defense mechanism: the role of nitric oxide. Immunoparasitol. TodayM 12 7 (1991) A17-A21
49. Liew F.Y., and O'Donnel C.A. Immunology of leishmaniasis. Adv. Parasitol. 32 (1993) 162-259
50. Liew F.Y., Millott S., Lelchuck R., Cobbold S., and Waldmann H. Effect of CD4 monoclonal antibody in vivo on lesion development, delayed-type hypersensitivity and interleukin-3 production in experimental murine cutaneous leishmaniasis. Clin. Exp. Immunol. 75 (1989) 438-443
51. Liew F.Y., Millot S., Parkinson C., Palmer R.M.J., and Moncada S. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from arginine. J. Immunol. 144 (1990) 4794-4797
52. Lima H.C., Bleyenberg J.A., and Titus R.G. A simple method for quantifying Leishmania in tissues of infected animals. Parasitol. Today 13 (1997) 80-82
53. Mackay C.R. Immunological memory. Adv. Immunol. 53 (1993) 217-265
54. MacKay C.R., Marston W.L., and Dudler L. Naive and memory T cells show distinct pathways of lymphocyte recirculation. J. Exp. Med. 171 (1990) 801-817
55. Mauel J., Betz-Corradin S., and Buchmuller-Rouiller Y. Nitrogen and oxygen metabolites and the killing of Leishmania by activated murine macrophages. Res. Immunol. 142 (1991) 577-580
56. Mauel J., Ransijn A., and Buchmuller-Rouiller Y. Killing of Leishmania parasites in activated murine macrophages is based on an L-arginine-dependent process that produces nitrogen derivatives. J. Leuk. Biol. 49 (1991) 73-82
57. McConville M., and Ferguson M.A.J. The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes. Biochem. J. 294 (1993) 305-324
58. McNeely T.B., and Turco S.J. Requirement of lipophosphoglycan for intracellular survival of Leishmania donovani within human macrophages. J. Immunol. 144 (1990) 2745-2750
59. Mendoza-Leon A., Shaw J.J., and Tapia F.J. A guide for the cutaneous leishmaniasis connoisseur. In: Tapia F.J., Caceres-Dittmar G., and Sanchez M.A. (Eds). Molecular and Immune Mechanisms in the Pathogenesis of Cutaneous Leishmaniasis (1996), R. G. Landes, Austin, TX 1-23
60. Menon J.N., and Bretscher P.A. Characterization of the immunological state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic chal-lenge. Eur. J. Immunol. 26 (1996) 243-249
61. Mitchell G.F. Murine cutaneous leishmaniasis: resistance in reconstituted nude mice and several Fl hybrids infected with Leishmania tropica major. J. Immunogenet. 10 (1983) 395-412
62. Mitchell G.F., Curtis J.M., and Handman E. Resistance to cutaneous leishmaniasis in genetically susceptible BALB/c mice. Aust. J. Exp. Biol. Med. Sci. 59 (1981) 555-565
63. Mitchell G.F., Curtis J.M., Scollay R., and Handman E. Resistance and abrogation of resistance to cutaneous leishmaniasis in reconstituted BALB/c nude mice. Aust. J. Exp. Biol. Med. 59 (1981) 539-554
64. Modabber F. Vaccine: the only hope to control leishmaniasis. In: Tapia F.J., Caceres-Dittmar G., and Sanchez M.A. (Eds). Molecular and Immune Mechanisms in the Pathogenesis of Cutaneous Leishmaniasis (1996), R. G. Landes, Austin, TX 222-236
65. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
66. Mosmann T.R., and Coffman R.L. Thl and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7 (1989) 145-173
67. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., and Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted protein. J. Immunol. 136 (1986) 2348-2357
68. Mosser D.M., and Edelson P.J. The third component of complement (C3) is responsible for the intracellular survival of Leishmania major. Nature 327 (1987) 329-331
69. Müllbacher A. The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen. J. Exp. Med. 179 (1994) 317-321
70. + T cells that promote parasite growth distinct from those mediating resistance?. Immunol. Lett. 19 (1988) 251-260
71. Müller I., Pedrazzini T., Farrell ].P., and Louis J. T-cell responses and immunity to experimental infection with Leishmania major. Annu. Rev. Immunol. 7 (1989) 561-578
72. +T cells. Int. Immunol. 3 (1991) 587-597
73. Nabors G.S. Modulating ongoing Th2-cell responses in experimental leishmaniasis. Parasitol. Today 13 (1997) 76-79
74. Nabors G.S., and Farrell J.P. Depletion of Interleukin-4 in BALB/c mice with established Leishmania major infections increases with the efficacy of antimony therapy and promotes Th-1 like responses. Infect. Immun. 62 (1994) 5498-5504
75. Nabors G.S., and Farrell J.P. Site-specific immunity to Leishmania major in SWR mice: the site of infection influcences susceptibility and expression of the antileishmanial immune response. Infect. Immun. 62 (1994) 3655-3662
76. Nabors G.S., Afonso L.C.C., Farrell J.P., and Scott P. Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin-12 and pen-tostam. Proc. Natl Acad. Sci. 92 (1995) 3142-3146
77. Nacy C.A., Fortier A.H., Pappas M.G., and Henry R.R. Susceptibility of inbred mice to Leishmania tropica infection: correlation of susceptibility with in vitro defective macrophage microbicidal activities. Cell. Immunol. 77 (1983) 298-307
78. Noben-Trauth N., Kropf P., and Miiller I. Susceptibility to Leishmania major infection in interleukin-4 deficient mice. Science 271 (1996) 987-990
79. Ohara J., and Paul W.E. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature 315 (1985) 333-336
80. Oswald I.P., Wynn T.A., Sher A., and James S.L. NO as an effector molecule of parasite killing: modulation of its synthesis by cytokines. Comp. Biochem. Physiol. 108C (1994) 11-18
81. PAHO, Communicable Disease Program. Leishmaniasis in the Americas. Epidemiol. Bull./PAHO 15 3 (1994) 8-13
82. Pearce E.J., and Reiner S.L. Induction of Th2 responses in infectious diseases. Curr. Opinion Immunol. 7 (1995) 497-504
83. Preston P.M., and Dumonde D.C. Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse. Clin. Exp. Immunol. 23 (1976) 126-138
84. Proudfoot L., Nikolaev A.V., Feng F.-J., Wei X.-Q., Ferguson M.A., Brimacombe J.S., and Liew F.Y. Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proc. Natl Acad. Sci. U S A 93 (1996) 10984-10989
85. Puentes S.M., Sacks D.L., Da Silva R.P., and Joiner K.A. Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of surface lipophosphoglycan. J. Exp. Med. 167 (1988) 887-902
86. Puentes S.M., Da Silva R.P., Sacks D.L., Hammer C.H., and Joiner K.A. Serum resistance of metacyclic stage Leishmania promastigotes is due to release of C5b-9. J. Immunol. 145 (1990) 4311-4316
87. Reiner S.L., and Locksley R.M. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13 (1995) 151-177
88. + T cells during initiation of infection. J. Exp. Med. 179 (1994) 447-456
89. Rodriguez V., Centeno M., and Ulrich M. The IgG isotypes of specific antibodies in patients with American cutaneous leishmaniasis; relationship to the cell-mediated immune response. Parasite Immunol. 18 (1996) 341-345
90. Sacks D.L., and Perkins P.V. Identification of an infective stage of Leishmania promastigotes. Science 223 (1984) 1417-1419
91. Sacks D.L., and Da Silva R.P. The generation of infective stage Leishmania major promastigotes is associated with the cell-surface expression and release of a developmentally regulated glycolipid. J. Immunol. 139 (1987) 3099-3106
92. Sacks D.L., Hieny S., and Sher A. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes. J. Immunol. 135 (1985) 564-569
93. + T cells secreting Thl or Th2. Immunity 2 (1995) 271-279
94. + T cells. J. Immunol. 139 (1987) 1303-1309
95. Sadick M.D., Heinzel F.P., Holaday B.J., Pu R.T., Dawkins R.S., and Locksley R.M. Cure of murine leishmaniasis with anti-interleukin-4 monoclonal antibody. Evidence for a T-cell-dependent, interferon-γ-independent mecha- nism. J. Exp. Med. 171 (1990) 115-127
96. Schneider P., Rosat J.-P., Bouvier J., Louis J., and Bordier C. Leishmania major: differential regulation of the surface metalloprotease in amastigote and promastigote stages. Exp. Parasitol. 75 (1992) 196-206
97. Scott P. The role of Thl and Th2 cells in experimental cutaneous leishma niasis. Exp. Parasitol. 68 (1989) 369-372
98. Scott P. IFN-γ modulates the early development of Thl and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 147 (1991) 3149-3155
99. Scott P.A., and Farrell J.P. Experimental cutaneous leishmaniasis: disseminated leishmaniasis in genetically susceptible and resistant mice. Am. J. Trop. Med. Hyg. 31 (1982) 230-238
100. + T-cell subsets in the regulation of parasite immunity and disease. Immunol. Rev. 112 (1989) 161-182
101. + T cells. Annu. Rev. Immunol. 12 (1994) 635-673
102. Sprent J. T and B memory cells. Cell 76 (1994) 315-322
103. + T cell response. J. Exp. Med. 181 (1995) 961-971
104. Sypek J.P., Chung C.L., Mayor S.E.H., Subramanyam J.M., Goldman S.J., Sieburth D.S., Wolf S.F., and Schaub R.G. Resolution of cutaneous leishmaniasis: Interleukin-12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177 (1993) 1797-1802
105. Taswell C. Limiting dilution assays for the separation, characterization, and quantitation of biologically active particles and their clonal progeny. In: Pretlow T.G., and Pretlow T.P. (Eds). Cell Separation: Methods and Selected Applications 4 (1987), Academic Press, London 109-145
106. Titus R.G., Ceredig R., Cerottini J.C., and Louis J.A. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically susceptible BALB/c mice. J. Immunol. 135 (1985) 2108-2114
107. Titus R.G., Marchand M., Boon T., and Louis J.A. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol. 7 (1985) 545-555
108. Turco S., and Descoteaux A. The lipophosphoglycan of Leishmania parasites. Annu. Rev. Microbiol. 46 (1992) 65-94
109. Turk J.L., and Bryceson A.D.M. Immunological phenomena in leprosy and related diseases. Adv. Immunol. 13 (1971) 209-266
110. Ulrich M., Rodriguez V., and Centeno M. The humoral response in leishmaniasis. In: Tapia F.J., Caceres-Dittmar G., and Sanchez M.A. (Eds). Molecular and Immune Mechanisms in the Pathogenesis of Cutaneous Leishmaniasis (1996), Landes, Austin, TX 189-202
111. Varkila K., Chatelain R., Leal L.M.C.C., and Coffman R.L. Reconstitution of C.B.-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection. Eur. J. Immunol. 23 (1993) 262-268
112. Vieira L.Q., Goldschmidt M., Nashleanas M., Pfeffer K., Mak T., and Scott P. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J. Immunol. 157 (1996) 827-835
113. + effector cells default to the Th2 pathway in interferon-γ-deficient mice infected with Leishmania major. J. Exp. Med. 179 (1994) 1367-1371
114. Wei X., Charles I.G., Smith A., Ure J., Feng G., Huang F., Xu D., Muller W., Moncada S., and Liew F.Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375 (1995) 408-411
115. World Health Organization. Biochemical Characterization of Leishmania (1982), UNDP/World Bank/WHO Special Programme, Geneva
116. World Health Organization. 12th Programme Report Leishmaniasis. Tropcial Disease Research. 20 Years of Progress (1995), World Health Organization, Geneva 135-146
117. Xu X., Sun Y., and Hoey T. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science 273 (1996) 794-797